Par Drugs and Chemicals Limited — Board Meeting, 29-08-2025: Outcome of Board Meeting
29-08-2025 | 05:57 pm
29-08-2025 | 05:57 pm
Par Drugs' board approved FY25 annual results. Key director re-appointments include Chairman & MD Falgun Savani and Independent Director Mrs. Bintal Shah. They also approved an Independent Director's annual fee of ₹0.24 Cr and a ₹0.29 Cr car for the CEO.
No comments yet. Be the first to comment!
